Metropolitan Life Insurance Co. NY trimmed its position in Anthem Inc (NYSE:ANTM) by 68.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,404 shares of the company’s stock after selling 85,372 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in Anthem were worth $8,866,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Nordea Investment Management AB grew its holdings in Anthem by 8.7% in the 3rd quarter. Nordea Investment Management AB now owns 4,215,569 shares of the company’s stock valued at $800,452,000 after buying an additional 339,111 shares in the last quarter. Geode Capital Management LLC grew its holdings in Anthem by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 2,864,024 shares of the company’s stock valued at $643,146,000 after buying an additional 51,003 shares in the last quarter. Viking Global Investors LP grew its holdings in Anthem by 190.5% in the 4th quarter. Viking Global Investors LP now owns 2,537,576 shares of the company’s stock valued at $570,980,000 after buying an additional 1,664,112 shares in the last quarter. Hotchkis & Wiley Capital Management LLC grew its holdings in Anthem by 0.5% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,393,810 shares of the company’s stock valued at $454,537,000 after buying an additional 12,975 shares in the last quarter. Finally, OppenheimerFunds Inc. grew its holdings in Anthem by 4.3% in the 4th quarter. OppenheimerFunds Inc. now owns 2,163,579 shares of the company’s stock valued at $486,826,000 after buying an additional 88,627 shares in the last quarter. 88.33% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Anthem Inc (NYSE:ANTM) opened at $228.11 on Friday. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 0.66. Anthem Inc has a 1 year low of $158.66 and a 1 year high of $267.95. The firm has a market capitalization of $58,816.04, a price-to-earnings ratio of 15.89, a P/E/G ratio of 1.33 and a beta of 0.87.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, January 31st. The company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.04. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The business had revenue of $22.45 billion during the quarter, compared to the consensus estimate of $22.17 billion. During the same period in the prior year, the company earned $1.76 EPS. Anthem’s revenue for the quarter was up 4.5% on a year-over-year basis. analysts predict that Anthem Inc will post 15.08 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 9th will be given a dividend of $0.75 per share. This is an increase from Anthem’s previous quarterly dividend of $0.70. This represents a $3.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. Anthem’s dividend payout ratio is currently 20.89%.
Anthem declared that its board has approved a stock repurchase plan on Thursday, December 7th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its shares are undervalued.
ANTM has been the topic of several analyst reports. Royal Bank of Canada reissued a “buy” rating on shares of Anthem in a report on Thursday, January 4th. ValuEngine raised Anthem from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Bank of America increased their target price on Anthem from $249.00 to $254.00 and gave the stock a “buy” rating in a report on Friday, November 17th. Credit Suisse Group reissued an “outperform” rating and set a $280.00 target price (up from $255.00) on shares of Anthem in a report on Thursday, February 1st. Finally, Jefferies Group raised Anthem from a “hold” rating to a “buy” rating and reduced their target price for the stock from $235.00 to $211.00 in a report on Friday, January 12th. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Anthem currently has an average rating of “Buy” and a consensus target price of $236.20.
In related news, SVP Ronald W. Penczek sold 1,966 shares of the company’s stock in a transaction on Wednesday, March 7th. The stock was sold at an average price of $231.90, for a total transaction of $455,915.40. Following the completion of the sale, the senior vice president now directly owns 2,132 shares in the company, valued at approximately $494,410.80. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Gloria M. Mccarthy sold 14,429 shares of the stock in a transaction dated Thursday, January 4th. The shares were sold at an average price of $229.68, for a total value of $3,314,052.72. Following the completion of the transaction, the executive vice president now owns 30,667 shares of the company’s stock, valued at $7,043,596.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 221,175 shares of company stock valued at $52,201,832. 0.36% of the stock is owned by corporate insiders.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.